Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder
|
Luke Timmerman |
11/20/09 |
Boston
|
|
Dendreon FDA Deadline Set For May 1
|
Luke Timmerman |
11/20/09 |
Seattle
|
|
Omeros Banks on First FDA Filing Next Year, Plans to “Unlock” Inaccessible Drug Targets
|
Luke Timmerman |
11/19/09 |
Seattle
|
|
ImmunoGen Nabs $1M From Amgen
|
Luke Timmerman |
11/19/09 |
Boston
|
|
Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore
|
Luke Timmerman |
11/19/09 |
Boston
|
|
Isis Extends Timeline on Cholesterol-Lowering Drug, FDA Delays Review of Cadence Pain Reliever, Fate Therapeutics Raises $30 Million, & More San Diego Life Sciences News
|
Denise Gellene |
11/19/09 |
San Diego
|
|
The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/19/09 |
Seattle
|
|
Genzyme Halts Development of New Kidney Drug; A “Very Significant” Bust, Analyst Says
|
Luke Timmerman |
11/18/09 |
Boston
|
|
Isis, Genzyme Cholesterol Drug Passes Test, But Investors Get Nervous About Liver Safety
|
Luke Timmerman |
11/17/09 |
San Diego
|
|
Trubion CEO Peter Thompson Steps Down, Arch’s Gillis To Step Up Temporarily
|
Luke Timmerman |
11/16/09 |
Seattle
|
|
Alkermes to Seek FDA Approval of Anti-Addiction Drug
|
Ryan McBride |
11/16/09 |
Boston
|
|
Cadence Hit By FDA Delay
|
Luke Timmerman |
11/13/09 |
San Diego
|
|
Genzyme Shares Tank After FDA Discovers Bits of Steel, Rubber in Five Different Drugs
|
Luke Timmerman |
11/13/09 |
Boston
|
|
Cequent Seeks First Oral RNAi Trial
|
Luke Timmerman |
11/12/09 |
Boston
|
|
Oncothyreon Advances Cancer Drug
|
Luke Timmerman |
11/12/09 |
Seattle
|
|
Alnylam Eyes RNAi for Manufacturing Drugs
|
Ryan McBride |
11/12/09 |
Boston
|
|
Trius Therapeutics Reveals Plans for IPO, SpectraScience Raises $4.3M, Sequenom Tightens its Belt, & More San Diego Life Sciences News
|
Denise Gellene |
11/12/09 |
San Diego
|
|
Isis Spinoff Altair Therapeutics Closes $17M Venture Round For Asthma Drug
|
Luke Timmerman |
11/12/09 |
San Diego
|
|
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target
|
Luke Timmerman |
11/11/09 |
Boston
|
|
Three New England Deal Stories: Startups Pursuing Emotional Sensors, Drugs for Pets, & Mobile Video Raise Some Bucks
|
Ryan McBride |
11/10/09 |
Boston
|
|
Clearwire Closes $1.5B, Alder Scores $1B Partnership, Software Financings Are Down, & More Seattle-Area Deals News
|
Gregory T. Huang |
11/10/09 |
Seattle
|
|
Ironwood Gets $75M Deal From Astellas to Market Bowel Drug in Asia
|
Luke Timmerman |
11/10/09 |
Boston
|
|
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer
|
Luke Timmerman |
11/10/09 |
Boston
|
|
Dendreon Burns $28M in Q3
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
San Diego’s PaxVax Developing Oral Tablet Vaccine, Looks to Raise More Cash With Support of Seattle’s Ignition Capital
|
Bruce V. Bigelow |
11/09/09 |
San Diego
|
|
Elias Zerhouni Talks Public Health Challenges, Culture Wars at WBBA Annual Meeting
|
Gregory T. Huang |
11/06/09 |
Seattle
|
|
Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer
|
Luke Timmerman |
11/05/09 |
Boston
|
|
Amylin Forms Global Alliance in Obesity Drug Development; TEDMED’s Show Will Go On, Sequenom Sued for Civil Fraud, & More San Diego Biotech News
|
Bruce V. Bigelow |
11/05/09 |
San Diego
|
|
Page 1 of
16 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
